SGP
SpyGlass Pharma, Inc.Company Information
- Company Name
- SpyGlass Pharma, Inc.
- CIK
- CIK0001778922
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- SGP: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- SGP
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-02-09
- Last sale
- —
- Shares purchased (TTM)
- 13,727,500
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 25,534,957
- Shares outstanding
- 33,439,543
- Ownership
- 76.36%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- 6.75%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||
| Cash And Cash Equivalents At Carrying Value | 223 | 239 | 96 | ||||||
| Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current | 11 | 12 | 11 | ||||||
| Other Receivables Net Current | 1 | 1 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 2 | 2 | 1 | ||||||
| Assets Current | 236 | 253 | 109 | ||||||
| Other Assets Noncurrent | 1 | 1 | 0 | ||||||
| Property Plant And Equipment Net | 5 | 3 | 2 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 2 | ||||||
| Assets | 243 | 258 | 116 | ||||||
Liabilities Current | |||||||||
| Accounts Payable Current | 4 | 4 | 3 | ||||||
| Employee Related Liabilities Current | 2 | 1 | 2 | ||||||
| Other Liabilities Current | 4 | 2 | 4 | ||||||
| Liabilities Current | 9 | 7 | 9 | ||||||
| Operating Lease Liability Current | - | 0 | 0 | ||||||
| Shares Subject To Mandatory Redemption Settlement Terms Amount Current | - | - | 0 | ||||||
| Operating Lease Liability Noncurrent | 2 | 2 | 2 | ||||||
| Liabilities | 11 | 8 | 10 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | 0 | 0 | 205 | ||||||
Equity | |||||||||
| Preferred Stock Value | 0 | 0 | - | ||||||
| Common Stock Value | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 371 | 369 | 6 | ||||||
| Retained Earnings Accumulated Deficit | -138 | -119 | -105 | ||||||
| Stockholders Equity | 232 | 250 | -99 | ||||||
| Liabilities And Stockholders Equity | 243 | 258 | 116 | ||||||
| Temporary Equity Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | ||||||
| Temporary Equity Shares Authorized | 0 | 0 | 117 | ||||||
| Temporary Equity Shares Issued | 0 | 0 | 20 | ||||||
| Temporary Equity Shares Outstanding | 0 | 0 | 20 | ||||||
| Temporary Equity Liquidation Preference | 0 | 0 | 201 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 200 | 200 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 1,000 | 1,000 | 154 | ||||||
| Common Stock Shares Issued | 33 | 33 | 2 | ||||||
| Shares Outstanding | 33 | 33 | 2 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialSpyGlass Pharma, Inc. (SGP) — SEC Financial Statements & Analysis
SpyGlass Pharma, Inc. (SGP) is a surgical & medical instruments & apparatus company, incorporated in DE. SpyGlass Pharma, Inc. trades on Nasdaq as: SGP. SpyGlass Pharma, Inc. (SGP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, SpyGlass Pharma, Inc. carries a market cap of $744.36M, a P/B ratio of 3.20x, and an enterprise value of $521.22M. On the balance sheet, it maintains a current ratio of 25.06x, a quick ratio of 24.89x, working capital of $227.02M, a debt-to-equity ratio of 0.05x, a debt ratio of 0.05, and net debt of $-223.14M. Figures sourced from SEC EDGAR.
- Market Cap
- $744.36M
- P/B TTM
- 3.20x
- Debt To Equity
- 0.05x
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is SpyGlass Pharma, Inc. in?
SpyGlass Pharma, Inc. (SGP) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does SGP trade on?
SpyGlass Pharma, Inc. (SGP) trades on the Nasdaq.
Where is SpyGlass Pharma, Inc. incorporated?
SpyGlass Pharma, Inc. is incorporated in DE.
When was SpyGlass Pharma, Inc. (SGP)'s most recent SEC filing?
SpyGlass Pharma, Inc. (SGP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is SGP's market cap?
SpyGlass Pharma, Inc. (SGP) has a market capitalization of $744.36M as of 2026-06-30.